Amgen Corp.
AMGN Buy Stats
On December 16, 1998, the Rule Breaker portfolio bought 290 shares of rule-breaking, biotech-leading Amgen Corp. (Nasdaq: AMGN). The price paid was $85 3/4 per share before commissions. For the buy report on Amgen which explains the company in detail and why it was bought, please click here.
ACTION: | Bought |
---|---|
TICKER: | AMGN |
PRICE: | $85 3/4 |
COMMISSION: | $8 |
TOTAL COST: | $24,875.50 |